Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Hyeon-cheol Jeong"'
Autor:
Do-Gyun Park, Hyeon-Cheol Jeong, Eun-Bin Jang, Jong-Mun Lee, Hyoung-Seok Lee, Hye-Ran Park, Sun-Il Lee, Taek-Keun Oh
Publikováno v:
Applied Biological Chemistry, Vol 67, Iss 1, Pp 1-10 (2024)
Abstract Biochar, with its potential to enhance soil fertility, sequester carbon, boost crop yields and reduce greenhouse gas emissions, offers a solution. Addressing the challenges posed by climate change is crucial for food security and agriculture
Externí odkaz:
https://doaj.org/article/cbf1fdd039d04d08b34dc3ec909cbd51
Autor:
Jung Yoon Yang, Dae-Seop Shin, Moonkyu Jeong, Seong Soon Kim, Ha Neul Jeong, Byung Hoi Lee, Kyu-Seok Hwang, Yuji Son, Hyeon-Cheol Jeong, Chi-Hoon Choi, Kyeong-Ryoon Lee, Myung Ae Bae
Publikováno v:
Pharmaceutics, Vol 16, Iss 5, p 574 (2024)
The blood-brain-barrier (BBB) is made up of blood vessels whose permeability enables the passage of some compounds. A predictive model of BBB permeability is important in the early stages of drug development. The predicted BBB permeabilities of drugs
Externí odkaz:
https://doaj.org/article/c6708021d4cc40d896428eaa2aa4ee4f
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 360 (2023)
Tegoprazan is a novel potassium-competitive acid blocker. This study investigated the effect of drug–drug interaction on the pharmacokinetics and pharmacodynamics of tegoprazan co-administered with amoxicillin and clarithromycin, the first-line the
Externí odkaz:
https://doaj.org/article/64e30ad15be94efba908135796e99bea
Autor:
Hyeon-Cheol Jeong, Min-Gul Kim, Zhuodu Wei, Kyeong-Ryoon Lee, Jaehyeok Lee, Im-Sook Song, Kwang-Hee Shin
Publikováno v:
Pharmaceutics, Vol 14, Iss 6, p 1298 (2022)
A physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) model for tegoprazan and its major metabolite M1 was developed to predict PK and PD profiles under various scenarios. The PBPK model for tegoprazan and M1 was developed and predicted u
Externí odkaz:
https://doaj.org/article/c63b3f3b1dc947cab71536f019664ccb
Publikováno v:
Pharmaceutics, Vol 13, Iss 4, p 522 (2021)
Pharmacometabolomics is a useful tool to identify biomarkers that can assess and predict response after drug administration. The primary purpose of pharmacometabolomics is to better understand the mechanisms and pathways of a drug by searching endoge
Externí odkaz:
https://doaj.org/article/02756a1df5eb4e3d83b8ad944a49c16f
Publikováno v:
Molecules, Vol 25, Iss 20, p 4625 (2020)
Metformin is the first-line medicine for the treatment of type 2 diabetes. Drug interactions between metformin and other drugs, food, or beverages cannot only cause changes in the pharmacokinetic profiles but also affect the efficacy of metformin. Th
Externí odkaz:
https://doaj.org/article/d1f9c6406b3a475ab7e1b791e32b5e6f
Autor:
Hyeon-Cheol Jeong, Soo Hyeon Bae, Jung-Woo Bae, Sooyeun Lee, Anhye Kim, Yoojeong Jang, Kwang-Hee Shin
Publikováno v:
Pharmaceutics, Vol 11, Iss 11, p 618 (2019)
Tramadol is a μ-opioid receptor agonist and a monoamine reuptake inhibitor. O-desmethyltramadol (M1), the major active metabolite of tramadol, is produced by CYP2D6. A physiologically-based pharmacokinetic model was developed to predict changes in t
Externí odkaz:
https://doaj.org/article/d20d2ec4aa554e2db33b67179e38d2f2
Publikováno v:
Translational & Clinical Pharmacology. Dec2022, Vol. 30 Issue 4, p201-211. 11p.
Autor:
Zhuodu Wei1, Hyeon-Cheol Jeong1, Ye-Ji Kang1, Jaesang Jang2, Myoung-Hwan Kim3, Kwang-Hee Shin1 kshin@knu.ac.kr
Publikováno v:
Translational & Clinical Pharmacology. Jun2022, Vol. 30 Issue 2, p99-111. 13p.
Publikováno v:
Translational & Clinical Pharmacology. Dec2021, Vol. 29 Issue 4, p226-238. 13p.